Welcome to another episode of Inline!
As we observe Breast Cancer Awareness Month this October, it is pertinent to raise awareness about the importance of early detection of breast cancer, which is the most common cancer affecting women globally. In this episode, we discuss various aspects of breast cancer, including its impact, risk factors, and the vital role of screening in improving outcomes.
Joining us is Dr. Ravi Teja, a renowned medical oncologist at Continental Hospitals, India. Dr. Teja highlights key global initiatives aimed at reducing breast cancer incidence, the role of mammography screening, and the importance of genetic testing in high-risk populations.
Dr. Teja emphasizes the impact of awareness campaigns, particularly in rural communities, and how they have improved early detection rates. Additionally, Dr. Teja discusses breast-conserving surgery, advances in treatment options, and the emotional and psychological support that patients and families need during and after treatment.
Key discussion points:
Initiatives Against Breast Cancer (1:17)
Regular mammograms starting at age 40, every two years until age 75. Family history may require earlier screenings.
Mass campaigning aims to raise awareness in rural communities through educational outreach, dispelling myths and encouraging screenings.
Mobile digital mammograms make screenings more accessible, especially in underserved areas.
Impact of Awareness on Diagnosis Rates (8:18)
Increased awareness has led to more women seeking screenings, resulting in earlier detection that is essential for successful treatment outcomes.
There is a reduction in patients presenting with late-stage cancer, indicating that awareness campaigns are effectively reaching their target audiences.
Role of Genetic Testing (10:27)
Genetic testing identifies mutations such as BRCA1 and BRCA2, crucial for women with a family history of breast cancer.
Early screenings and preventive measures, like prophylactic surgeries, can reduce the risk for those testing positive.
Post-Diagnosis Actions for Patients (12:50)
Immediate consultation with an oncologist is encouraged instead of exploring alternative treatments, ensuring timely care.
The cure rates for breast cancer are promising: approximately 90% of patients diagnosed with early-stage breast cancer (stage I, II, and III) are cured.
Even in stage IV breast cancer, about 70% of patients can achieve long-term remission.
Criteria for Breast-Conserving Surgery (15:52)
Suitable for stage 1 and 2 patients, with exceptions for certain conditions like inflammatory breast cancer.
Surgical advancements allow effective tumor removal while preserving breast tissue, addressing concerns about mastectomy.
Monitoring Health Post-Treatment (18:26)
Annual mammograms and monthly self-exams are critical for detecting recurrences early
High-risk patients benefit from tailored follow-up care, with frequent visits in the first few years after treatment
Support for Patients and Families (19:34)
A positive home environment and family involvement are key to helping patients cope with treatment
Emotional support, including access to support groups and counseling, is vital for patients' mental health during recovery
Take-Home Messages:
Regular mammograms and early detection improve treatment outcomes, with mammograms starting at age 40 or earlier for those with a family history.
Raising awareness, particularly in rural areas, can dispel stigma and educate women on the importance of regular screenings.
Identifying harmful mutations like BRCA1 and BRCA2 allows women to take proactive steps, including early screenings and preventive surgeries.
A strong support network, including family, friends, and healthcare professionals, is essential in helping patients cope with breast cancer and navigate their treatment journey.
With new, less invasive treatment options and improved survival rates, breast cancer is no longer a death sentence. Early detection and modern therapies make recovery more achievable.
After treatment, regular follow-ups and self-exams are vital to catching recurrences early, ensuring patients stay on top of their health post-treatment.
About Dr. Ravi Teja:
Dr. Ravi Teja is a highly skilled medical oncologist at Continental Hospitals in Hyderabad, with expertise in managing leukemia, lymphoma, breast cancer, lung cancer, and colon cancer. As a certified European Medical Oncologist, Dr. Teja is committed to delivering cutting-edge care, adhering to the latest international standards. Before joining Continental Hospitals, he served as an Assistant Professor of Medical Oncology at NIMS, Hyderabad, where he made significant contributions to patient care and medical education, mentoring future oncologists. Dr. Ravi Teja is also actively involved in cancer research, exploring innovative treatments to improve patient outcomes, showcasing his dedication to advancing oncology and enhancing patient well-being.
Linkedin Profile: https://in.linkedin.com/in/ravi-teja-banda-b640782a3
Relevant links:
Website - https://www.decodemr.com/
Linkedin - https://in.linkedin.com/company/decodemr
Twitter - https://twitter.com/decode_mr
Facebook- https://www.facebook.com/decodeMR/